社论：“间质性膀胱炎/膀胱疼痛综合征（IC/BPS）中的生物标志物”特刊
Editorial: Special Issue "Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)".
作者信息
Neuhaus Jochen, Gonsior Andreas, Berndt-Paetz Mandy
机构信息
Research Laboratory, Department of Urology, University of Leipzig, 04103 Leipzig, Germany.
Department of Urology, University Hospital Leipzig AöR, 04103 Leipzig, Germany.
出版信息
Diagnostics (Basel). 2022 Jul 11;12(7):1689. doi: 10.3390/diagnostics12071689.
Abstract
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a disabling chronic disease of still unknown origin and complex pathophysiology [...].
摘要
间质性膀胱炎/膀胱疼痛综合征（IC/BPS）是一种致残性慢性疾病，病因不明且病理生理复杂[...]。
相似文献
1
Editorial: Special Issue "Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)".
Diagnostics (Basel). 2022 Jul 11;12(7):1689. doi: 10.3390/diagnostics12071689.
2
Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Diagnostics (Basel). 2021 Dec 29;12(1):75. doi: 10.3390/diagnostics12010075.
3
Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai - India.
Anesth Pain Med. 2020 May 12;10(3):e101848. doi: 10.5812/aapm.101848. eCollection 2020 Jun.
4
Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
Diagnostics (Basel). 2021 Nov 30;11(12):2238. doi: 10.3390/diagnostics11122238.
5
Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Urol Int. 2019;102(1):109-112. doi: 10.1159/000493507. Epub 2018 Nov 14.
6
Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis.
Urology. 2011 Mar;77(3):576-80. doi: 10.1016/j.urology.2010.10.016. Epub 2011 Jan 7.
7
Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder.
Transl Androl Urol. 2015 Oct;4(5):524-33. doi: 10.3978/j.issn.2223-4683.2015.08.01.
8
Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
Biomedicines. 2022 Jul 14;10(7):1701. doi: 10.3390/biomedicines10071701.
9
A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Eur Urol. 2018 Nov;74(5):623-630. doi: 10.1016/j.eururo.2018.07.026. Epub 2018 Jul 30.
10
Current best practice management of interstitial cystitis/bladder pain syndrome.
Ther Adv Urol. 2018 Mar 19;10(7):197-211. doi: 10.1177/1756287218761574. eCollection 2018 Jul.
本文引用的文献
1
Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Diagnostics (Basel). 2022 Apr 27;12(5):1093. doi: 10.3390/diagnostics12051093.
2
Lectins as Biomarkers of IC/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC/BPS Experimental Models.
Diagnostics (Basel). 2022 Apr 25;12(5):1078. doi: 10.3390/diagnostics12051078.
3
The Role of Urinary VEGF in Observational Studies of BPS/IC Patients: A Systematic Review.
Diagnostics (Basel). 2022 Apr 20;12(5):1037. doi: 10.3390/diagnostics12051037.
4
Bladder Microbiome in the Context of Urological Disorders-Is There a Biomarker Potential for Interstitial Cystitis?
Diagnostics (Basel). 2022 Jan 22;12(2):281. doi: 10.3390/diagnostics12020281.
5
Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Diagnostics (Basel). 2021 Dec 29;12(1):75. doi: 10.3390/diagnostics12010075.
6
Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome.
Diagnostics (Basel). 2021 Dec 23;12(1):19. doi: 10.3390/diagnostics12010019.
7
MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies.
Diagnostics (Basel). 2021 Dec 8;11(12):2298. doi: 10.3390/diagnostics11122298.
8
Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
Diagnostics (Basel). 2021 Nov 30;11(12):2238. doi: 10.3390/diagnostics11122238.
9
Biomarkers in the Light of the Etiopathology of IC/BPS.
Diagnostics (Basel). 2021 Nov 29;11(12):2231. doi: 10.3390/diagnostics11122231.
10
β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?
Diagnostics (Basel). 2021 Nov 10;11(11):2082. doi: 10.3390/diagnostics11112082.
Zotero 插件